Endothelial cells (EC) play a key role in the inflammatory response, both by the production of proinflammatory cytokines and by their interaction with leukocytes. Molecular genetic analysis has demonstrated that functional NF-KB sites are involved in the transcription of interleukin-6 (IL-6). IL-8, and granulocyte-macrophage colony-stimulating factor (GM-CSF) genes in response t o inflammatory mediators. Thus, we have explored the effect of two inhibitors of the NF-KB activation, pyrrolidine dithiocarbamate (PDTC) and Nacetylcysteine (NAC), on the production of these cytokines by EC. Both PDTC and NAC inhibited, in a dose-dependent manner, the synthesis of IL-6, IL-8, and GM-CSF induced by tumor necrosis factor (TNF )-a or bacterial lipopolysaccharides (LPS) in human umbilical vein endothelial cells (HUVEC). PDTC appeared t o prevent IL-6, IL-8, and GM-CSF gene transcription, as it blocked the induction of specific mRNA by TNF-a or LPS. The TNF-a-mediated transcriptional activation of a chloramphenicol acetyltransferase (CAT) plas-NDOTHELIAL CELLS (EC) are important producers E of and targets for cytokines, the soluble factors that play a key role in the onset and maintenance of the principal processes involved in the inflammatory response.',' Proinflammatory stimuli, such as interleukin-1 (IL-l), tumor necrosis factor (TNF)-a, and bacterial lipopolysaccharides (LPS), elicit on EC the production of IL-6, IL-8, and granulocyte-macrophage colony-stimulating factor (GM-CSF), ' and induce the expression of several adhesion molecules.' Most of these molecules actively participate in the adhesion cascade that is responsible for the leukocyte-endothelial cell interactions that occur at sites of inflammation.' Thus, IL-8 attracts neutrophils and T lymphocytes, whereas GM-CSF attracts both monocytes and neutrophils towards the inflammatory f~c i .~,~ In a subsequent phase of the white cells recruitment process, these cytokines trigger a strong leukocyte adhesion by increasing the expression andor turning on the active conformation of leukocyte integrin~,~.~ which bind to their endothelial ligands, intercellular adhesion mole-mid containing three copies of the -72 KB binding site from the 11-6 promoter was abrogated by PDTC. According t o transfection experiments, electrophoretic mobility shift assays (EMSA) demonstrated that the antioxidant prevented the induction of NF-KB DNA-binding activity by TNF-a. Under the same conditions, PDTC by itself or in combination with TNF-a, enhanced the DNA-binding activity of AP-1, as well as c-fos and c-jun mRNA levels. Altogether, these results indicate that the antioxidant PDTC specifically inhibits the transcription of IL-6, IL-8, and GM-CSF genes through the inhibition of the NF-KB activation, while increasing the expression of AP-1. Our data make evident the antiinflammatory and immunoregulatory potential of the pharmacological inhibition of the NF-KB activation. In addition, PDTC and related molecules may be a useful tool t o explore the expression of genes involved in the inflammatory response. 0 1996 by The American Society of Hematology.
cule (ICAM-1) and vascular cell adhesion molecule (VCAM-1). Finally, the extravasation and migration of the white cells towards the inflammatory foci is directed by IL-8 and other ~hemokines.~
The response of endothelium to proinflammatory stimuli might be tightly regulated by the redox status of the cell. In this regard, it has been demonstrated that the antioxidants pyrrolidine dithiocarbamate (PDTC) and N-acetylcysteine (NAC) are able to inhibit the expression of VCAM-1 and tissue factor genes induced by proinflammatory stimuli on EC.6-8 The mechanism underlying this effect likely involves the regulation of both signal transduction' and activity of transcription factors such as NF-KB, an ubiquitous factor that functions as an immediate early activator of genes involved in inflammatory and immune response." Antioxidant agents such as cysteine derivates, dithiocarbamates, and iron chelators have been reported to inhibit NF-KB activation in a specific manner, indicating that the reactive oxygen intermediates (ROIs) have a regulatory role on NF-KB activation." Other transcription factors besides NF-KB seem to be regulated by the redox status of the cell. Thus, the DNAbinding activity of AP-1 is regulated by redox modification of conserved cysteine residues in the DNA-binding domain of c-jun and c -f o~. '~ In addition, in HeLa cells, the transactivation and the DNA-binding activity of AP-1 are induced with the antioxidative enzyme thioredoxine or the antioxidants PDTC and NAC. These data suggest that AP-1 transcription factor may function as an antioxidant responsive element (ARE).I3
The IL-6, IL-8, and GM-CSF genes contain functional NF-KB binding sites in their promoters that have been demonstrated to be necessary for the transcriptional activation of these genes.I4-l9 Therefore, we decided to explore the effect of PDTC and NAC, two specific inhibitors of the NF-KB activation, on the induction of these cytokines in response to inflammatory stimuli in human EC. 3482 Blood, Vol 88, No 9 (November 1). 1996: pp 3482-3490
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MATERIALS AND METHODS
Human umbilical vein endothelial cells (HU-VEC) were isolated from normal human umbilical cord veins. The umbilical vein was cannulated and incubated with 1% Collagenase for 15 minutes at 37°C. Following removal of collagenase, cells were pooled and established as primary cultures in medium 199 (GIBCO, Gaithersburg, MD) containing 20% fetal calf serum (FCS). HUVEC were serially passaged and maintained using medium 199 supplemented with 20% FCS, 50 pg/mL endothelial cell growth factor and 100 pg/mL heparin in tissue culture flasks precoated with 0.5% gelatin. Cells were used within the first six passages.
TNF-a (3.2 X lo7 U/mg) was purchased from Wichem (Vienna, Austria). LPS (Escherichia coli 055:BS), PDTC, and NAC were purchased from Sigma Chemical Co (St Louis, MO). Undetectable levels of endotoxin were found in cultured supernatants of resting and cytokine-stimulated cells by using a limulus amebocyte lysate assay kit (Whittaker, Wakersville, MD).
4B9 IgGl monoclonal antibody (MoAb) (anti-VCAM-1) was generously provided by Dr J. Harlan (University of Washington, Seattle, WA). P3X63 IgGl myeloma culture supernatant was used as negative control.
The rabbit antisera against Fos family (RR26/8) and Jun family (636/6) were kindly provided by Dr Rodrigo Bravo (Bristol Myers Squibb, Princeton, NJ)
Culture conditions and enzyme-linked immunosorbent assays (ELISA). HUVEC were grown to confluence on 24-well tissue culture plates. Medium was removed and replaced with fresh medium containing 10% FCS with or without 50 pmol/L PDTC or 25 mmoY L NAC for 1 hour. Then, 25 ng/mL TNF-a or 50 ng/mL LPS were added either to the untreated or PDTC/NAC-pretreated cells without removing the antioxidants. After incubation for 6 or 24 hours at 37"C, supernatant was collected and tested for IL-6, IL-8, and GM-CSF release. HUVEC monolayer was then washed and cells were analyzed for cell surface antigen expression by flow cytometry (see below). Cell viability by staining with fluorochrome propidium iodide was stimated to rule out the possibility that s6me of the inhibitory effects of PDTC and NAC were due to toxicity. Under the experimental conditions and in the range of PDTC and NAC concentrations used, cell viability was always higher than 90% (data not shown). In addition, when PDTC-treated HUVEC (in which IL-6 induction and VCAM-1 upregulation mediated by TNF-(r were inhibited) were washed and further cultured with fresh medium for an additional period of 24 hours, the restimulation of the cells with TNF-a resulted in an induction of IL-6NCAM-1 indistinguishable from that observed in the cells cultured in parallel that were not exposed to PDTC (data not shown).
IL-6 concentration was measured by a sandwich ELISA in which CLB-IL-6/16 anti-IL-6 MoAb and an affinity purified sheep anti-IL-6 polyclonal antibody (a kind gift of Dr L.A. Aarden, University of Amsterdam, Amsterdam, The Netherlands) were used for the capture and detection of IL-6, respectively. The assay was essentially performed as described,'" except for the amplification step that was replaced by incubation with streptavidine-horseradish peroxidase complexes. IL-8 and GM-CSF production was determined using commercially available kits (Quantikine, R&D Systems, Minneapolis, MN) according to manufacturer's instructions.
After collecting supernatant to measure cytokine production, HUVEC were removed from tissue culture plates. Cells were washed with phosphate-buffered saline (PBS) and incubated at 4°C for 30 minutes with 1:5000 diluted 4B9 MoAb ascites in PBS buffer, followed by washing and labeling with an fluorescein isothiocyanate (FITC)-conjugated rabbit F(ab)'* antimouse IgG (Dakopatts, Glostrup, Denmark). Samples were analyzed Endothelial cells.
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by flow cytometry in a FACScan cytofluorometer (Becton Dickinson, Mountain View, CA).
Total cellular RNA was isolated by using the guanidium isothiocyanatelCsC1 method, as previously described." HUVEC were either untreated or pretreated for 1 hour with PDTC, and then 25 ng/mL TNF-(r or 50 ng/ mL LPS were added to the cells without removing PDTC. After 4 hours of incubation, HUVEC were washed with PBS and lysed with 4 moln guanidium isothiocyanate. The cell lysate was layered on a cushion of 5.7 molL CsCl and ultracentrifugated at 35,000 rpm for 18 hours. Purified RNA from each sample (20 pg per lane) was denatured, electrophoresed through an 1 % formaldehyde agarose gel, and blotted onto a nitrocellulose membrane that was hybridized with 32P-labeled IL-8 cDNA (kindly provided by Dr J. Oppenheim, NCI-FCRDC, Frederick, MD), and sequentially probed either with IL-6 and GM-CSF cDNA (kindly provided by Dr J.M. Alvaro Gracia, Hospital de la Princesa, Madrid, Spain) or c-fos and c-jun cDNA (a kind gift of Dr P. Angel, D.K.Z., Heidelberg, Germany).
The NF-KB-dependent CAT reporter plasmid pIL-6CAT59lILREx3 contains three copies of the -72 KB motif of the IL-6 gene inserted upstream to position-59 of the pIL-6CAT 59, which itself is transcriptionally ina~tive,'~ and was a kind gift from Dr K. Yamamoto (Kanazawa University, Kanazawa, Japan). Plasmids containing the wild-type or the mutant -72 KB sequence placed in front of the thymidine kinase promoter and CAT structural gene have previously been describedI5 and were kindly provided by Drs J. Vilcek (New York University Medical Center, New York, NY) and E. Benveniste (University of Alabama at Birmingham, Birmingham, AL).
HUVEC were plated at near confluence in 35 mm culture dishes and 24 hours later were transfected with 2.5 pg of plasmid DNA per mL by using a standard calcium phosphate technique.*' Briefly, HUVEC were incubated with precipitated DNA for 6 hours, washed with PBS, and cultured with fresh complete 199 medium for 18 hours. Then, transfected cells were exposed to different stimuli for 12 hours, and CAT activity was measured according to instructions of a CAT ELISA kit (Boehringer Manheim, Manheim, Germany)
Small scale nuclear extracts were prepared from HUVEC as described'' with some modifications. Briefly, cells were washed once with PBS and twice with buffer A. The cell pellet was then resuspended (10' cells/100 pL) in buffer A/O.l% Nonidet P-40, and incubated for 10 minutes. Lysed cells were microcentrifuged for 20 minutes, supernatant was discarded, and nuclear pellet was extracted with 3 volumes of buffer C in the presence of D-L-Dithiotreitol (DTT) and protease inhibitors. Nuclear pellet volume was estimated to correct the final KCI concentration to 400 mmol/L. After 30 minutes of incubation, nuclei were microcentrifuged for 30 to 45 minutes, and the supernatant was diluted with 4 volumes of buffer D modified to contain 50 mmol/L KCl instead of 100 mmoVL. EMSAs were performed as de~cribed.'~ Briefly, 4 pg of nuclear protein were incubated for 10 minutes at 4°C in a total volume of 12.5 pL containing 1 pg of poly(d1-dC) DNA carrier and 5.5 p L of binding buffer, with or without 30-fold molar excess of unlabeled oligonucleotide. For serologic characterization of the nuclear complexes, 1 pL of each polyclonal antiserum against Fos and Jun families were preincubated with the nuclear extracts at 4°C for 30 minutes before the addition of the probe. Then, 1 X lo5 cpm (10' c p d p g ) of annealed "I-labeled oligonucleotides were added and incubated at room temperature for 20 minutes. Samples were subjected to electrophoresis on a 4% polyacrylamide gel. The sequences of the synthetic oligonucleotides used as probes in RNA isolation and Northern blot analysis.
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Bgl I1 compatible ends were appended for radiolabeling with the Klenow fragment of the DNA pol I.
RESULTS
Endothelial cells play a key role in the inflammatory response. These cells synthesize several chemotactic and proinflammatory cytokines in response to both physiological (C5a, IL-I, TNF-a) or nonphysiological (LPS) stimuli.' We have explored the effect of PDTC and NAC, two inhibitors of the NF-KB activation, on the synthesis of several cytokines by EC.
The incubation of HUVEC with TNF-a or LPS during 24 hours resulted in a strong enhancement of IL-6, IL-8, and GM-CSF secretion that was detected as early as 6 hours after treatment (Fig IA, and data preincubated for 60 minutes with 50 pmol/L. PDTC, there was a marked downregulation of the induction of cytokine release mediated by TNF-a or LPS (Fig IA) . Similar results were obtained with NAC ( Fig 1A) . Dose-response experiments showed that the inhibitory effect of PDTC on cytokine synthesis was detectable at a dose of 20 pmol/L, with a maximal suppression at doses of 50 pmol/L PDTC (Fig 1 B) .
This inhibitory effect of the antioxidants was not due to cell toxicity, since in the range of PDTC and NAC concentrations used, the cell viability was always higher than 90% (see Materials and Methods).
To further explore the mechanisms involved in this suppressive effect, we performed Northern blot analysis on EC stimulated with TNF-a or LPS in the presence of PDTC. We found undetectable or very low levels of IL-6, IL-8, 
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and GM-CSF mRNA in unstimulated HUVEC (Fig 2) . The exposure of these cells to TNF-a or LPS during 4 hours resulted in a strong upregulation of TL-6, TL-8, and GM-CSF transcripts, an effect that was almost completely abrogated when HUVEC were simultaneously treated with PDTC ( Fig  2) . The specificity of this inhibition was examined by studying the effect of this dithiocarbamate on the expression of c-jun and c-fos mRNA levels, as it has been previously demonstrated that the transcription of these genes is induced by PDTC in HeLa cells." Treatment of HUVEC with the antioxidant resulted in an accumulation of c-jun and c-fos mRNA levels that were further augmented when EC were cotreated with PDTC and TNF-a (Fig 3A and data not  shown) . The induction of c-jun mRNA by PDTC was detectable after 30 minutes, reached a maximum at aproximately 
.
2 hours, and persisted for long periods of time (Fig 3A and  data not shown) . In the presence of TNF-a and PDTC, there was a further augmentation of the c-jun mRNA levels under conditions in which the induction of IL-8 mRNA was completely inhibited. The induction of c-fos mRNA by PDTC began to increase at 30 minutes, reached a maximum at 60 minutes, and decreased after 3 hours, but cotreatment with PDTC and TNF-a resulted in a longer lasting induction of c-fos mRNA (data not shown). Since c-jun is an early responsive gene (the previous experiments were performed at 3 and 5 hours after activation), we also studied the effect of PDTC on a gene that is induced later in the endothelial cell activation response. As shown in Fig 3B, 20 hours of treatment with PDTC did not affect the TNF-a-mediated ICAM-1 mRNA induction, whereas it inhibited the induction of IL- (Fig  4) . When cells were cotreated with PDTC plus TNF-(U, a further incrcasc in IL-8 mRNA hulf-lifc was dctcctcd (Fig   4) . thus indicating that the inhibitory effects of PDTC were not due to alteration on the rnRNA stability.
Deletional and mutational analyses have demonstrated that the transcription factor NF-KB is involved in the activa- tion of IL-6, IL-8, and GM-CSF genes by proinflammatory mediator^.'^-'^ To further investigate if PDTC selectively inhibited transcriptional activation of these genes, HUVEC were transiently transfected with a reporter construct containing three copies of the -72 KB site of the E-6 5'-flanking region placed upstream of the homologous minimal promoter. As shown in Fig 5A , the TNF-a stimulatory effect was inhibited by the antioxidant, indicating that the main effect of PDTC is at the transcriptional level. To confirm that NK-KB activation is required for the induction of these genes in HUVEC, we used CAT reporter constructs containing the wild-type or the mutant -72 KB sequence of the IL-6 gene. With the wild-type IL-6 KB construct, the transcriptional activity of CAT reporter plasmid was significantly increased after treatment with TNF-a (Fig 5B) . HOWever, on transfection of the mutant KB sequence, no transcription of the CAT gene was detected with TNF-a. In addition, the transcriptional activity of the wild-type KB plasmid induced by TNF-a was inhibited by PDTC, thus indicating that this antioxidant exerted its effect by inhibiting the activation of NF-KB.
In agreement with the transfection experiments, EMSAs showed that the basal levels of NF-KB DNA-binding activity detected on nuclear extracts from unstimulated HUVEC were significantly increased after exposure of the cells to TNF-a (Fig 6) . The enhancement of NF-KB binding activity induced by TNF-a was prevented by the treatment of HU-VEC with PDTC (Fig 6) . Since the initial experiments indicate that PDTC induced significant mRNA levels of c-jun and c-fos, we also investigated the presence of AP-1 protein complexes with DNA-binding activity in the nuclear extracts. The treatment of H W E C with 50 or 100 pmol/L PDTC for 4 hours resulted in a strong enhancement of the DNA-binding activity of AP-1 that was further increased in nuclear extracts from HUVEC treated simultaneously with TNF-a and PDTC (Fig 6) . Supershift experiments using antisera against Jun and Fos demonstrated that both antisera completely prevented the formation of specific complexes indicating the presence of members of Fos and Jun families of transcription factors in the complex (data not shown). These results indicate that PDTC activates AP-1 DNA-binding activity in human EC, whereas under identical conditions, it inhibits the induction NF-KB complexes mediated by TNF-a.
DISCUSSION
The production of IL-6, IL-8, and GM-CSF is increased at sites of inflammati~n.*-~,*~,~~ Both IL-8 and GM-CSF are chemotactic cytokines involved in leukocyte trafficking. In a first step, the cytokine is retained on endothelium in solid phase and acts as an immobilized ligand for trapping a specific type of leukocyte. Subsequent binding of chemokines (ie, IL-8) or cytokines (ie, GM-CSF) to leukocytes results in an activation of leukocyte integrins, and the cells become firmly adhered to the endothelium. After strong adhesion to EC, the leukocyte migrates toward the inflammed tissue under the influence of a chemotactic
On the other hand, IL-6 promotes the proliferation of vascular smooth muscle cells and increases the permeability of EC,25 events that are involved in the onset and development of conditions such as vasculitis and atherosclerosis. Given the pathologic relevance of the phenomena considered above, the cytokine production by EC is presumably a crucial target in the therapy for different inflammatory processes.
In this regard, we demonstrate that PDTC and NAC molecules inhibit the production and mRNA expression of cyto- 
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promoter-driven CAT activity induced by TNF-a and does not destabilize IL-8 mRNA, suggesting that this antioxidant inhibits cytokine production mainly at the transcriptional level. CAT assays performed with wild-type, mutant, and trimerized -72 KB sequence of the IL-6 gene. together with EMSAs, in which a reduction of the TNF-a-induced NF-KB DNA-binding activity was detected, showed that the nuclear factor NF-KB is a crucial element to confer inducibility by TNF-CY and inhibition by PDTC. These results confirm the molecular evidence that cytokine-or LPS-induced activation of the promoters of these cytokines may critically depend on NF-KB activation in HUVEC. In this regard, it is important to point out that the activation of NF-KB is indispensable for IL-6 and IL-8 genes activation in any type of cell examined."-IX In addition, molecular analysis of IL-6 and IL-8 suppression by different agents such as glucocorticoids, estrogens, IFN--y, cyclosporin, or FKS06 showed that all of them affected the activity of NF-KB, thereby suppressing the transcription of these ~ytokines."~~" Our results strongly suggest that this is also the case for PDTC. Various studies have proposed that, although NF-KB is the most crucial factor for IL-6 and IL-8 gene transcription, cooperation with other transcription factor, NF-IL6, is necessary for the activation of these genes. as demonstrated by mutation of either NF-KB or NF-IL6 binding sites and cotransfection experiments with expression vectors of NF-IL6 and NF-KB subunits.." Hence, it will be also interesting to define the effects of PDTC on the activity
The activation of GM-CSF gene expression in response to different extracellular stimuli is somewhat more complex, of NF-IL6. and the activation of GM-CSF promoter requires the interaction of NF-KB with other transcription factor families."-M Therefore, the final effect of PDTC on the activity of this promoter would require a more detailed analysis.
To control for possible nonspecific effects of PDTC on EC gene expression, we study the effect of the antioxidant on the expression of genes whose transcription is apparently independent of NF-KB.".?' We found that PDTC by itself or in cooperation with TNT-a lead to an increase in the mRNA levels of c-jiin and c~fos. whereas it inhibited the TNF-amediated inducibility of IL-6, IL-8, and GM-CSF. Moreover, PDTC did not affect the induction of ICAM-I mRNA by TNF-a after 20 hours of coculture. Finally, DNA-binding activities of AP-1 was augmented by PDTC or PDTCRNFa cotreatment, whereas under the same conditions, the antioxidant inhibited the induction of NF-KB DNA-binding activity mediated by TNF-a, thus adding molecular evidence for the specificity of the inhibitory effect of PDTC. Collectively, these data suggest that NF-KB activation can represent a common and necessary step for the transcription of several genes involved in the establishment of the inflammatory response. As a consequence, the inhibition of the NF-KB pathway by dithiocarbamates may constitute a single and critical target for therapeutic intervention in those pathologies associated with abnormal cytokine secretion. In this regard, it has been described that the progression of HIV-infected patients to acquired immune deficiency syndrome (AIDS) is clearly related to the overproduction of cytokines, a phenomenon derived from the uncontrolled activation of lymphocytes seen in these patients." Thus, the beneficial effect of For personal use only. on October 23, 2017 . by guest www.bloodjournal.org From dithiocarbamates reported in HIV+ individuals3* could be related to the downregulation of cytokine synthesis induced by these drugs.
NF-KB activation takes place following the phosphorylation of the inhibitory subunit 1~B -a that may serve as the signal for its subsequent proteolytic degradation by the 26s protea~ome.~~.~' In this regard, pharmacological inhibitors of either 1~B -a phosphorylation or proteasome activity have been demonstrated to inhibit the activation of NF-KB and subsequently the transcription of EC adhesion molecules genes dependent on functional KB site^.^',^^ Similarly, PDTC is able to abrogate cytokine-or LPS-induced transcription of these same adhesion molecules and tissue factor activity in EC, as well as cytokine production by monocyte^.^-^.^^
The mechanism of action of PDTC has not yet been well defined, but probably involves the inhibition of reactive oxygen intermediates (ROI) generation that would result in the activation of an 1~B -a kinase, or alternatively, in the activation of a process involved in the phosphorylation of the inhibitor of NF-KB.",'~,~~ Casein kinase I1 has been recently suggested as the 1~B -a kinase.4o
Regarding the transcription factor AP-1, the results from EMSA and Northern blot experiments suggest that it may function as an antioxidant responsive transcription factor in human EC, as it has been demonstrated in other cell systems." The enhanced DNA-binding activity of AP-1 might contribute to repress cytokine gene activation mediated by NF-KB. In this regard, Fos and Jun have been shown to interact with NF-IL6 and repress transcription activation by this factor.48 As stated above, NF-IL6 activation is also necessary for the activation of IL-6 and IL-8 genes and its inhibition could account, together with the inhibition of NF-KB activation, for the inhibitory effect of the antioxidant on the transcription of these cytokines. It will be interesting to determine the overall effect of PDTC on the transcription and subsequent expression of different genes on EC, as well as other cells.
In addition to the therapeutic potential in autoimmune and inflammatory diseases, dithiocarbamates can represent an invaluable tool to investigate the role of NF-KB and AP-I transcription factors in the expression of genes associated with the inflammatory response in human EC.
